Receptor-Targeted Therapies in Diabetes Mellitus: From Pathophysiology to Innovative Treatments (Endocrinology Research and Clinical Developments)

個数:

Receptor-Targeted Therapies in Diabetes Mellitus: From Pathophysiology to Innovative Treatments (Endocrinology Research and Clinical Developments)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 言語 ENG
  • 商品コード 9798895305874

Full Description

This book is a comprehensive academic text that delves into the complex mechanisms and therapeutic potential of various receptors and enzymes implicated in diabetes mellitus. Beginning with an in-depth introduction to the pathophysiology of diabetes mellitus, this book lays the groundwork for understanding the multifaceted nature of the disease. Each subsequent chapter is dedicated to a specific receptor or enzyme, exploring their roles in metabolic regulation, glucose homeostasis, and insulin secretion. The text covers a range of crucial targets, including free fatty acid receptors (FFAR1/GPR40 and FFAR4/GPR120), insulin receptors (IR), glucagon-like peptide-1 receptors (GLP-1R), peroxisome proliferator-activated receptors (PPARs), sodium-glucose cotransporter 2 (SGLT2) inhibitors, alpha-glucosidase inhibitors, SIRT1, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), G-protein-coupled receptors, adenosine monophosphate-activated protein kinase (AMPK), muscarinic acetylcholine receptors (mAChRs), protein tyrosine phosphatase 1B (PTP1B), and fructose 1,6-bisphosphatase (FBPase). This book not only elaborates on the biochemical and physiological roles of these targets but also discusses the latest therapeutic strategies aimed at modulating their activity for effective diabetes management. Readers will gain insights into how these receptor-targeted therapies can enhance insulin secretion, improve glycemic control, and regulate metabolic processes. The final chapter provides a forward-looking perspective on emerging trends and future research directions in receptor-targeted diabetes therapies, emphasizing the potential of personalized medicine in transforming diabetes care. Rich in scientific detail and clinical relevance this book bridges the gap between basic research and clinical application, making it an indispensable guide for those dedicated to advancing diabetes treatment and improving patient outcomes. Whether used as an educational tool or a reference for cutting-edge research, this book promises to be an authoritative source of knowledge in the field of diabetes therapeutics. This book is designed to serve as a valuable resource for medical students, graduate students, researchers, clinicians, and healthcare professionals interested in the advanced study of diabetes and its treatments.

最近チェックした商品